Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.45% |
| 4 | Miscellaneous | 11.59% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1226
DELISTED
SpringWorks Therapeutics
SWTX
| $4.35M | ﹤0.01% |
152,373
+139,337
| +1,069% | +$3.99M |
|
|
PPLI
1227
People Inc
PPLI
$2.98B
| $4.34M | ﹤0.01% |
95,534
+30,163
| +46% | +$1.7M |
|
1228
Idacorp
IDA
$7.51B
| $4.32M | ﹤0.01% |
43,670
-679
| -2% | -$74K |
|
1229
e.l.f. Beauty
ELF
$5.87B
| $4.31M | ﹤0.01% |
114,546
+66,976
| +141% | +$2.42M |
|
1230
Papa John's
PZZA
$644M
| $4.31M | ﹤0.01% |
61,519
+18,043
| +42% | +$1.53M |
|
|
VSEE
1231
DELISTED
VSEE HEALTH INC
VSEE
| $4.3M | ﹤0.01% |
424,225
| – | – |
|
1232
Armstrong World Industries
AWI
$6.88B
| $4.3M | ﹤0.01% |
54,214
+40,634
| +299% | +$3.44M |
|
1233
Franklin Electric
FELE
$4.29B
| $4.29M | ﹤0.01% |
52,541
-1,605
| -3% | -$137K |
|
|
TTM
1234
DELISTED
Tata Motors Limited
TTM
| $4.28M | ﹤0.01% |
176,582
-10,760
| -6% | -$302K |
|
|
ARBG
1235
DELISTED
Aequi Acquisition Corp
ARBG
| $4.28M | ﹤0.01% |
428,655
| – | – |
|
1236
Teradata
TDC
$2.69B
| $4.28M | ﹤0.01% |
137,627
-30,649
| -18% | -$1.07M |
|
|
DNZ
1237
DELISTED
D and Z Media Acquisition Corp.
DNZ
| $4.26M | ﹤0.01% |
432,139
| – | – |
|
1238
PUT
Lockheed Martin
LMT
$120B
| $4.25M | ﹤0.01% |
11,000
| – | – |
|
1239
Ciena
CIEN
$50.6B
| $4.24M | ﹤0.01% |
104,736
+17,394
| +20% | +$836K |
|
|
PGRE
1240
DELISTED
Paramount Group
PGRE
| $4.24M | ﹤0.01% |
679,686
-32,254
| -5% | -$232K |
|
|
FOLD
1241
DELISTED
Amicus Therapeutics
FOLD
| $4.23M | ﹤0.01% |
405,521
+387,185
| +2,112% | +$4.31M |
|
1242
PUT
ZTO Express
ZTO
$14.7B
| $4.23M | ﹤0.01% |
176,000
| – | – |
|
1243
InterDigital
IDCC
$8.62B
| $4.23M | ﹤0.01% |
104,637
+86,419
| +474% | +$4.66M |
|
|
ITOS
1244
DELISTED
iTeos Therapeutics
ITOS
| $4.23M | ﹤0.01% |
221,843
+192,220
| +649% | +$4.43M |
|
1245
Nexstar Media Group
NXST
$4.99B
| $4.21M | ﹤0.01% |
25,251
+2,553
| +11% | +$473K |
|
|
VRE
1246
DELISTED
Veris Residential
VRE
| $4.21M | ﹤0.01% |
370,549
-63,773
| -15% | -$857K |
|
|
GRDI
1247
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
| $4.21M | ﹤0.01% |
425,712
| – | – |
|
1248
Dutch Bros
BROS
$5.23B
| $4.21M | ﹤0.01% |
135,061
+89,558
| +197% | +$3.37M |
|
1249
SkinHealth Systems
SKIN
$86.5M
| $4.2M | ﹤0.01% |
355,827
+160,327
| +82% | +$2.03M |
|
|
CFIV
1250
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $4.18M | ﹤0.01% |
420,235
+281,021
| +202% | +$2.78M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays deployed $5.45B of net new capital in Q3 2022, opening 261 new positions and adding to 1,854 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $873M trimmed.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.